ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2465

Prevelance Of Inflammatory Back Pain and Axial Spondyloarthritis Among University Employees In Izmir, Turkey

Fatos Onen1, Dilek Solmaz1, Pinar Cetin1, Ali Balci2, Servet Akar1 and Nurullah Akkoc1, 1Rheumatology, Dokuz Eylul University School of Medicine, Izmir, Turkey, 2Radiology, Dokuz Eylul University School of Medicine, izmir, Turkey

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Back pain and spondylarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondylarthropathies and Psoriatic Arthritis: Clinical Aspects and Treatment III

Session Type: Abstract Submissions (ACR)

Background/Purpose:

The prevalence of axial spondyloarthritis (SpA) has not yet been investigated in a population based survey by using new ASAS classification criteria. The aim of this study was to determine the prevalence of axial SpA among university employees in Izmir, Turkey.

Methods:

The study was conducted in the Health Sciences Campus with a population of 2894 medical and non-medical staff at Dokuz Eylul University in Izmir. A sample size of 395 subjects was calculated by assuming that the inflammatory back pain (IBP) prevalence of 5% in the general population (1) using OpenEpi (version 2.3 Atlanta, GA, USA), based on a confidence interval of ±2%. Six trained medical students using a standard questionnaire performed a face-to-face interview with participants. The subjects who were classified as having IBP based on ASAS Experts’ criteria and other IBP criteria sets were invited to the Rheumatology out-patient clinic to participate in the study. They were evaluated for axial SpA by two rheumatologists using ASAS classification criteria. The patients with IBP were also evaluated to determine whether they met the modified New York (mNY) criteria for ankylosing spondylitis (AS) and both the ESSG and the Amor criteria for SpA.

Results:

A total of 381 subjects (131 male, 250 female; mean age: 38.0 ± 9.4) were contacted with an acceptance rate of 96.5%. Twenty five subjects (6.5 %; CI 95% 4.0-9.0) with back pain lasting ≥ 3 months were classified as having IBP according to ASAS Experts’ criteria. The prevalence of IBP according to Berlin and Calin criteria was found to be 7.0% (CI 95% 4.0-10.0) and 21.5% (CI 95% 17.0-25.0), respectively (Table).

Three subjects with IBP (0.78%) were classified as having axial SpA according to ASAS classification criteria. Two of these patients (0.52%) had radiographic sacroiliitis and they met the mNY criteria for AS . There were 8 patients (2.0%) who fulfilled both the Amor and ESSG criteria for whole group of SpA (Table). One of them had psoriasis.

Conclusion:

This is the first population-based survey of axial SpA using ASAS classification criteria. The prevalence estimates of IBP and SpA/axial SpA reported in this study are within the upper range of other studies in European countries and US.

Table. Prevalence of IBP and SpA according to various classification criteria in the university employees

 

Total % (CI 95%)

Female % (CI 95%)

Male % (CI 95%)

IBP Criteria

 

 

 

    ASAS Experts’

6.5 (4.0-9.0)

8.0 (5.0-12.0)

3.0 (1.0-8.0)

    Berlin

7.0 (4.0-10.0)

8.0 (5.0-12.0)

3.0 (1.0-8.0)

    Calin

21.5 (17.0-25.0)

24.2 (19.0-29.0)

16.0 (11.0-24.0)

ASAS Criteria for Axial SpA

0.78 (0.16-2.30)

0.80 (0.097-2.89)

0.70 (0.02-4.25)

MNY Criteria for AS

0.52 (0.06-1.80)

0.40 (0.01-2.20)

0.70 (0.02-4.25)

Amor Criteria for SpA

2.00 (0.90-4.00)

2.40 (0.88-5.22)

1.40 (0.18-5.50)

ESSG Criteria for SpA

2.00 (0.90-4.00)

2.40 (0.88-5.22)

1.40 (0.18-5.50)

IBP: inflammatory back pain; SpA: spondyloarthritis; MNY: modified New York; ESSG: European Spondyloarthropathy Study Group

Reference 1. Weismann MH et al. The prevalence of inflammatory back pain: population-based estimates from the US National Health and Nutrition Examination Survey, 2009-10. Ann Rheum Dis 2013 Mar;72(3):369-73


Disclosure:

F. Onen,
None;

D. Solmaz,
None;

P. Cetin,
None;

A. Balci,
None;

S. Akar,
None;

N. Akkoc,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prevelance-of-inflammatory-back-pain-and-axial-spondyloarthritis-among-university-employees-in-izmir-turkey/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology